Clinical Trials Directory

Trials / Sponsors / Jiangsu Gensciences lnc.

Jiangsu Gensciences lnc.

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
Severe Hemophilia A
Phase 32026-12-25
RecruitingPhase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Severe Hemophilia A
Phase 32023-12-27
CompletedSS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment
Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 1 / Phase 22023-10-12
CompletedA Phase I of SS109 in Hemophilia A or and B With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency
Phase 12022-12-14
CompletedA Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Severe Hemophilia A
Phase 22022-04-14
CompletedA Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor V
Severe Hemophilia A
Phase 12021-06-22
CompletedA Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Pro
Hemophilia A
Phase 12021-06-16